Citigroup’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $892K | Sell |
36,024
-15,673
| -30% | -$373K | ﹤0.01% | 3192 |
|
|
2025
Q4 | $1.21M | Buy |
51,697
+1,446
| +3% | +$32.2K | ﹤0.01% | 3015 |
|
|
2025
Q3 | $990K | Sell |
50,251
-77,509
| -61% | -$1.59M | ﹤0.01% | 3169 |
|
|
2025
Q2 | $2.77M | Sell |
127,760
-124,628
| -49% | -$2.94M | ﹤0.01% | 2369 |
|
|
2025
Q1 | $6.12M | Buy |
252,388
+32,654
| +15% | +$735K | ﹤0.01% | 1729 |
|
|
2024
Q4 | $4.59M | Buy |
219,734
+64,240
| +41% | +$1.38M | ﹤0.01% | 2048 |
|
|
2024
Q3 | $3.09M | Buy |
155,494
+40,383
| +35% | +$749K | ﹤0.01% | 2283 |
|
|
2024
Q2 | $1.78M | Sell |
115,111
-375,593
| -77% | -$5.85M | ﹤0.01% | 2443 |
|
|
2024
Q1 | $7.82M | Buy |
490,704
+284,860
| +138% | +$4.29M | 0.01% | 1412 |
|
|
2023
Q4 | $3.46M | Sell |
205,844
-52,482
| -20% | -$717K | ﹤0.01% | 1838 |
|
|
2023
Q3 | $3.02M | Sell |
258,326
-28,081
| -10% | -$376K | ﹤0.01% | 1722 |
|
|
2023
Q2 | $3.85M | Sell |
286,407
-145,897
| -34% | -$2.1M | ﹤0.01% | 1666 |
|
|
2023
Q1 | $7.17M | Buy |
432,304
+143,137
| +49% | +$2.36M | 0.01% | 1309 |
|
|
2022
Q4 | $5.38M | Sell |
289,167
-135,470
| -32% | -$2.09M | ﹤0.01% | 1440 |
|
|
2022
Q3 | $5.45M | Buy |
424,637
+216,408
| +104% | +$2.56M | ﹤0.01% | 1504 |
|
|
2022
Q2 | $1.46M | Buy |
208,229
+149,302
| +253% | +$1.1M | ﹤0.01% | 2345 |
|
|
2022
Q1 | $489K | Sell |
58,927
-152,908
| -72% | -$1.08M | ﹤0.01% | 3526 |
|
|
2021
Q4 | $1.43M | Buy |
211,835
+79,539
| +60% | +$523K | ﹤0.01% | 2902 |
|
|
2021
Q3 | $701K | Sell |
132,296
-162,208
| -55% | -$887K | ﹤0.01% | 3370 |
|
|
2021
Q2 | $1.69M | Sell |
294,504
-378,729
| -56% | -$1.95M | ﹤0.01% | 2793 |
|
|
2021
Q1 | $3.1M | Buy |
673,233
+652,727
| +3,183% | +$2.59M | ﹤0.01% | 2178 |
|
|
2020
Q4 | $68K | Buy |
20,506
+12,796
| +166% | +$43K | ﹤0.01% | 5823 |
|
|
2020
Q3 | $23K | Sell |
7,710
-111,168
| -94% | -$435K | ﹤0.01% | 6080 |
|
|
2020
Q2 | $549K | Sell |
118,878
-32,951
| -22% | -$148K | ﹤0.01% | 4163 |
|
|
2020
Q1 | $585K | Sell |
151,829
-49,301
| -25% | -$202K | ﹤0.01% | 3728 |
|
|
2019
Q4 | $754K | Buy |
201,130
+111,656
| +125% | +$522K | ﹤0.01% | 4043 |
|
|
2019
Q3 | $475K | Buy |
89,474
+62,542
| +232% | +$333K | ﹤0.01% | 4382 |
|
|
2019
Q2 | $103K | Buy |
26,932
+787
| +3% | +$3.4K | ﹤0.01% | 5844 |
|
|
2019
Q1 | $134K | Buy |
26,145
+833
| +3% | +$2.45K | ﹤0.01% | 5471 |
|
|
2018
Q4 | $49K | Sell |
25,312
-1,165
| -4% | -$3.33K | ﹤0.01% | 6262 |
|
|
2018
Q3 | $100K | Buy |
26,477
+4,287
| +19% | +$13.4K | ﹤0.01% | 5905 |
|
|
2018
Q2 | $69K | Sell |
22,190
-16,940
| -43% | -$51.4K | ﹤0.01% | 6025 |
|
|
2018
Q1 | $94K | Buy |
39,130
+31,928
| +443% | +$106K | ﹤0.01% | 5671 |
|
|
2017
Q4 | $28K | Buy |
7,202
+7,067
| +5,235% | +$23.3K | ﹤0.01% | 6539 |
|
|
2017
Q3 | $0 | Sell |
135
-45
| -25% | -$123 | ﹤0.01% | 7267 |
|
|
2017
Q2 | $0 | Sell |
180
-3,908
| -96% | -$8.16K | ﹤0.01% | 7347 |
|
|
2017
Q1 | $8K | Hold |
4,088
| – | – | ﹤0.01% | 6628 |
|
|
2016
Q4 | $4K | Hold |
4,088
| – | – | ﹤0.01% | 6968 |
|
|
2016
Q3 | $4K | Sell |
4,088
-7,350
| -64% | -$6.62K | ﹤0.01% | 6820 |
|
|
2016
Q2 | $8K | Sell |
11,438
-62,174
| -84% | -$50.1K | ﹤0.01% | 6623 |
|
|
2016
Q1 | $86K | Buy |
73,612
+50,896
| +224% | +$79K | ﹤0.01% | 5761 |
|
|
2015
Q4 | $56K | Buy |
22,716
+22,704
| +189,200% | +$65K | ﹤0.01% | 5847 |
|
|
2015
Q3 | $0 | Sell |
12
-967
| -99% | -$4.17K | ﹤0.01% | 7416 |
|
|
2015
Q2 | $4K | Buy |
979
+951
| +3,396% | +$3.79K | ﹤0.01% | 6849 |
|
|
2015
Q1 | $0 | Buy |
+28
| New | +$101 | ﹤0.01% | 7220 |
|
|
2014
Q4 | – | Sell |
-10,096
| Closed | -$34K | – | 7128 |
|
|
2014
Q3 | $34K | Buy |
10,096
+6,558
| +185% | +$17.1K | ﹤0.01% | 5553 |
|
|
2014
Q2 | $9K | Buy |
+3,538
| New | +$7.56K | ﹤0.01% | 6205 |
|
|
2014
Q1 | – | Sell |
-500
| Closed | -$1K | – | 7033 |
|
|
2013
Q4 | $1K | Hold |
500
| – | – | ﹤0.01% | 6848 |
|
|
2013
Q3 | $2K | Buy |
+500
| New | +$841 | ﹤0.01% | 6578 |
|
Other funds holding CPRX
VCM
DM
VPM
Citigroup's CPRX Position: Q1 2026 in Review
Citigroup reduced its Catalyst Pharmaceutical (CPRX) stake by 30% in Q1 2026, selling an estimated $373K and leaving 36,024 shares worth $892K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.
Citigroup first reported a position in CPRX in Q3 2013 and has held it in 49 quarters since. The position peaked at $7.82M in Q1 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Citigroup held 36,024 shares of Catalyst Pharmaceutical worth $892K as of Q1 2026.
- Citigroup sold 15,673 Catalyst Pharmaceutical shares in Q1 2026, an estimated $373K.
- Catalyst Pharmaceutical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3192 holding.
- Citigroup first reported a position in Catalyst Pharmaceutical in Q3 2013 and has held it in 49 quarters since.
- Citigroup's Catalyst Pharmaceutical position peaked at $7.82M in Q1 2024.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.